Galena Biopharma (GALE) Misses Q4 EPS by 7c

Galena Biopharma (NASDAQ: GALE) reported Q4 EPS of ($0.12), $0.07 worse than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M